Advertisement

Journal of Nuclear Cardiology

, Volume 24, Issue 2, pp 625–648 | Cite as

What is the evidence? A call for scientific rigor

Fourteenth Annual Mario S. Verani, MD, Memorial Lecture
  • Raymond J. GibbonsEmail author
Original Article

Introduction

Thank you Ami for those kind words of introduction. During the 1980s, I interfaced extensively with Mario Verani. I can recall when he first told me that he was going to start working on adenosine for pharmacologic stress, which led to this landmark paper in Circulation. 1 (Figure  1) Subsequently he, Frans Wackers, and I collaborated on the development of Tc-99m sestamibi for acute infarction imaging, which led to this paper on planar imaging 2 (Figure  2) and this paper on SPECT imaging 3 (Figure  3). My most extensive contact with Mario was when we both served on an ACCF/AHA Guidelines Committee on Radionuclide Imaging, which was chaired by Jim Ritchie and included Tim Bateman and Bob Bonow 4 (Figure  4). Mario believed in scientific rigor. I believe that he would approve of my focus today on the need for scientific rigor in our field. In the first half of this lecture, I will focus on past lessons from these five areas (Table  1); in the second half of this lecture, I will...

Keywords

Amyloidosis Cardiac Sarcoidosis Scientific Rigor Coronary Calcium Score Thallium Imaging 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Notes

Disclosure

Dr. Gibbons has consulting relationships with Lantheus Medical Imaging, Astellas Pharmaceuticals, and Peer View Institute.

References

  1. 1.
    Verani MS, Mahmarian JJ, Hixson JB, Boyce TM, Staudacher RA. Diagnosis of coronary artery disease by controlled coronary vasodilation with adenosine and thallium-201 scintigraphy in patients unable to exercise. Circulation 1990;82:80-7.CrossRefPubMedGoogle Scholar
  2. 2.
    Wackers FJ, Gibbons RJ, Verani MS, Kayden DS, Pellikka PA, Behrenbeck T, et al. Serial quantitative planar technetium-99m isonitrile imaging in acute myocardial infarction: Efficacy for noninvasive assessment of thrombolytic therapy. J Am Coll Cardiol 1989;14:861-73.CrossRefPubMedGoogle Scholar
  3. 3.
    Gibbons RJ, Verani MS, Behrenbeck T, Pellikka PA, O’Connor MK, Mahmarian JJ, et al. Feasibility of tomographic technetium-99m-hexakis-2-methylpropyl-isonitrile imaging for the assessment of myocardial area at risk and the effect of acute treatment in myocardial infarction. Circulation 1989;80:1277-86.CrossRefPubMedGoogle Scholar
  4. 4.
    Ritchie J, Bateman TM, Bonow RO, Crawford MH, Gibbons RJ, Hall RJ et al. Guidelines for clinical use of cardiac radionuclide imaging. A report of the American Heart Association/American College of Cardiology Task Force on Assessment of Diagnostic and Therapeutic Cardiovascular Procedures, Committee on Radionuclide Imaging, developed in collaboration with the American Society of Nuclear Cardiology. Circulation 1995;91:1278-303.Google Scholar
  5. 5.
    Hlatky MA, Greenland P, Arnett DK, Ballantyne CM, Criqui MH, Elkind MS, et al. Criteria for evaluation of novel markers of cardiovascular risk: A scientific statement from the American Heart Association. Circulation 2009;119:2408-16.CrossRefPubMedPubMedCentralGoogle Scholar
  6. 6.
    Patel MR, Peterson ED, Dai D, Brennan JM, Redberg RF, Anderson HV, et al. Low diagnostic yield of elective coronary angiography. N Engl J Med 2010;362:886-95.CrossRefPubMedPubMedCentralGoogle Scholar
  7. 7.
    Gibbons RJ, Chatterjee K, Daley J, Douglas JS, Fihn SD, Gardin JM, et al. ACC/AHA/ACP-ASIM guidelines for the management of patients with chronic stable angina: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Patients with Chronic Stable Angina). J Am Coll Cardiol 1999;33:2092-197.CrossRefPubMedGoogle Scholar
  8. 8.
    Poornima IG, Miller TD, Christian TF, Hodge DO, Bailey KR, Gibbons RJ. Utility of myocardial perfusion imaging in patients with low-risk treadmill scores. J Am Coll Cardiol 2004;43:194-9.CrossRefPubMedGoogle Scholar
  9. 9.
    Kwok JMF, Christian TF, Miller TD, Hodge DO, Gibbons RJ. Incremental prognostic value of exercise single-photon emission computed tomographic (SPECT) thallium 201 imaging in patients with ST-T abnormalities on their resting electrocardiograms. Am Heart J 2005;149:145-51.CrossRefPubMedGoogle Scholar
  10. 10.
    Lauer MS, Pothier CE, Magid DJ, Smith SS, Kattan MW. An externally validated model for predicting long-term survival after exercise treadmill testing in patients with suspected coronary artery disease and a normal electrocardiogram. Ann Intern Med 2007;147:821-8.CrossRefPubMedGoogle Scholar
  11. 11.
    Wilson PW, Jacques P, Selhub J, D’Agostino R, O’Donnell CJ. C-reactive protein and reclassification of cardiovascular risk in the Framingham Heart Study. Circ Cardiovasc Qual Outcomes 2008;1:92-7.CrossRefPubMedPubMedCentralGoogle Scholar
  12. 12.
    Hachamovitch R, Hayes SW, Friedman JD, Cohen I, Berman DS. Comparison of the short-term survival benefit associated with revascularization compared with medical therapy in patients with no prior coronary artery disease undergoing stress myocardial perfusion single photon emission computed tomography. Circulation 2003;107:2900-7.CrossRefPubMedGoogle Scholar
  13. 13.
    Montalescot G, Sechtem U, Achenbach S, Andreotti F, Arden C, Budaj A, et al. 2013 ESC guidelines on the management of stable coronary artery disease. The Task Force on the management of stable coronary artery disease of the European Society of Cardiology. Eur Heart J 2013;34:2949-3003.CrossRefPubMedGoogle Scholar
  14. 14.
    Hachamovitch R, Nutter B, Hlatky MA, Shaw LJ, Ridner ML, Dorbala S, et al. Patient management after noninvasive cardiac imaging results from SPARC (Study of myocardial perfusion and coronary anatomy imaging roles in coronary artery disease). J Am Coll Cardiol 2012;59:462-74.CrossRefPubMedGoogle Scholar
  15. 15.
    Mahmarian JJ, Moye L, Verani MS, Eaton T, Francis M, Pratt CM. Criteria for the accurate interpretation of changes in left ventricular ejection fraction and cardiac volumes as assessed by rest and exercise gated radionuclide angiography. J Am Coll Cardiol 1991;18:112-9.CrossRefPubMedGoogle Scholar
  16. 16.
    van Royen N, Jaffe CC, Krumholz HM, Johnson KM, Lynch PJ, Natale D, et al. Comparison and reproducibility of visual echocardiographic and quantitative radionuclide left ventricular ejection fractions. Am J Cardiol 1996;77:843-50.CrossRefPubMedGoogle Scholar
  17. 17.
    Chung H, McClelland RL, Katz R, Carr JJ, Budoff MJ. Repeatability limits for measurement of coronary artery calcified plaque with cardiac CT in the multi-ethnic study of atherosclerosis. Am J Roentgenol 2008;190:W87-92.CrossRefGoogle Scholar
  18. 18.
    Chung ES, Leon AR, Tavazzi L, Sun JP, Nihoyannopoulos P, Merlino J, et al. Results of the predictors of response to CRT (PROSPECT) trial. Circulation 2008;117:2608-16.CrossRefPubMedGoogle Scholar
  19. 19.
    Vesely MR, Li S, Kop WJ, Reese A, Marshall J, Shorofsky SR, et al. Test-retest reliability of assessment for intraventricular dyssynchrony by tissue Doppler imaging echocardiography. Am J Cardiol 2008;101:645-50.CrossRefPubMedGoogle Scholar
  20. 20.
    Hawkins NM, Petrie MC, Burgess MI, McMurray JJ. Selecting patients for cardiac resynchronization therapy: The fallacy of echocardiographic dyssynchrony. J Am Coll Cardiol 2009;53:1944-59.CrossRefPubMedGoogle Scholar
  21. 21.
    Shaw L, Berman D, Maron DJ. Optimal medical therapy with or without percutaneous coronary intervention to reduce ischemic burden. Circulation 2008;117:1283-91.CrossRefPubMedGoogle Scholar
  22. 22.
    Gibbons RJ, Miller TD. Should extensive myocardial ischaemia prompt revascularization to improve outcomes in chronic coronary artery disease? Eur Heart J 2015;36:2281-7.CrossRefPubMedGoogle Scholar
  23. 23.
    Velazquez EJ, Lee KL, Deja MA, Jain A, Sopko G, Marchenko A, et al. Coronary-artery bypass surgery in patients with left ventricular dysfunction. N Engl J Med 2011;364:1607-16.CrossRefPubMedPubMedCentralGoogle Scholar
  24. 24.
    Amsterdam EA, Wenger NK, Brindis RG, Casey DE Jr, Ganiats TG, Holmes DR Jr, et al. 2014 AHA/ACC Guideline for the management of patients with non-ST-elevation acute coronary syndromes: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 2014;64:e139-228.CrossRefPubMedGoogle Scholar
  25. 25.
    Hoffmann U, Truong QA, Schoenfeld DA, Chou ET, Woodard PK, Nagurney JT, et al. Coronary CT angiography versus standard evaluation in acute chest pain. N Engl J Med 2012;367:299-308.CrossRefPubMedPubMedCentralGoogle Scholar
  26. 26.
    Diagnostic standard and guidelines for sarcoidosis. Jpn J Sarcoidosis Granulomatous Disord 2007;27:89-102. Google Scholar
  27. 27.
    Judson M, Costabel U, Wells D, Koth L, Shigemitsu H, Culver DG, Gelfand J, et al. The WASOG Sarcoidosis Organ Assessment Instrument: An update of a previous clinical tool. Sarcoidosis Vasc Diffuse Lung Dis 2014;31:19-27.PubMedGoogle Scholar
  28. 28.
    Birnie DH, Sauer WH, Bogun F, Cooper JM, Culver DA, Duvernoy CS, et al. HRS expert consensus statement on the diagnosis and management of arrhythmias associated with cardiac sarcoidosis. Heart Rhythm 2014;11:1304-23.CrossRefGoogle Scholar
  29. 29.
    Blankstein R, Osborne M, Naya M, Waller A, Kim CK, Murthy VL, et al. Cardiac positron emission tomography enhances prognostic assessments of patients with suspected cardiac sarcoidosis. J Am Coll Cardiol 2014;63:329-36.CrossRefPubMedGoogle Scholar
  30. 30.
    Gillmore JD, Maurer MS, Falk RH, Merlini G, Damy T, Dispenzieri A, et al. Nonbiopsy diagnosis of cardiac transthyretin amyloidosis. Circulation 2016;133:2404-12.CrossRefPubMedGoogle Scholar
  31. 31.
    Castano A, Haq M, Narotsky DL, Goldsmith J, Weinberg RL, Morgenstern R, et al. Multicenter study of planar technetium 99m pyrophosphate cardiac imaging: Predicting survival for patients with ATTR cardiac amyloidosis. JAMA Cardiol 2016;1:880-9.CrossRefPubMedGoogle Scholar

Copyright information

© American Society of Nuclear Cardiology 2016

Authors and Affiliations

  1. 1.Department of Cardiovascular DiseasesMayo Clinic College of Medicine and ScienceRochesterUSA

Personalised recommendations